REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/15/2025
Back to search
Official data from USPTO
HITGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
09/16/2025
Trademark type
Combined
Nice classes
1, 5, 35, 42
Filing date
04/11/2019
Registration date
09/15/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/15/2020
Last transaction
09/16/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
CN
Examiner
CAPSHAW, DANIEL
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "HITGEN" with the letter I in red and the other letters in blue. The color "white" appears as background only and is not claimed as a feature of the mark.
Holders and representatives
Holders
HitGen Inc.
HITGEN LTD.
Representatives
Eric J Maiers Greenberg Traurig, LLP
Technical classification
Nice Classes
Class 1Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical reagents other than for medical or veterinary purposes; biological reagents other than for medical or veterinary purposes; biochemical catalysts; DNA encoded chemical compound for use in biochemical research; DNA encoded chemical preparations for use in biochemical research; intermediate of DNA encoded chemical compound for use in biochemical research; headpiece of DNA encoded chemical compound for use in biochemical research
Class 5
Medicines for human purpose for treatment of cancerinflammationimmune diseasescardiovascular diseasemetabolic disease or ophthalmic diseases; chemical preparations for medical purpose for treatment of cancerinflammationimmune diseasescardiovascular diseasemetabolic disease or ophthalmic diseases; chemical preparations for pharmaceutical purpose for treatment of cancerinflammationimmune diseasescardiovascular diseasemetabolic disease or ophthalmic diseases; chemico-pharmaceutical preparations for treatment of cancerinflammationimmune diseasescardiovascular diseasemetabolic disease or ophthalmic diseases
Class 35
Shop window dressing; outdoor advertising; bill-posting; distribution of samples; publicity services
Class 42
Technical project studiestechnical research in the field of pharmaceutical studies; chemical research services; chemical research; biological research; research and development services relating to DNA encoded library synthesis; research and development services relating to DNA encoded library selection; research and development services relating to DNA encoded library data analysis
Publications
History of USPTO decisions and trademark events.
25 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/08/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/10/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/23/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/31/2020
FIMP
FINAL DISPOSITION PROCESSED
12/30/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/15/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/15/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/30/2020
PUBO
PUBLISHED FOR OPPOSITION
06/30/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/10/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/27/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/19/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/18/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/18/2020
RFNT
REFUSAL PROCESSED BY IB
01/24/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/04/2020
RFRR
REFUSAL PROCESSED BY MPU
01/04/2020
MAFR
APPLICATION FILING RECEIPT MAILED
12/07/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/05/2019
CNRT
NON-FINAL ACTION WRITTEN
12/04/2019
DOCK
ASSIGNED TO EXAMINER
12/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/03/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/27/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/21/2019
Continuous trademark protection
Get notified about every new filing that threatens HITGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.